Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
23-valent pneumococcal polysaccharide vaccine in nursing home residents
jRCT1090220024Completed
- Sponsor
- Mie University
- Start
- Nov 2008
- Modality
- Split/Subunit Vaccines → Inactivated Vaccines → Prophylactic Vaccines → Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Randomised, double-blind trial in Pneumococcal pneumonia (PP) and pneumonia comparing 23-valent pneumococcal polysaccharide vaccine with Placebo (sodium chloride) (2 arms). Primary endpoints: Incidence of pneumonia, Incidence of pneumococcal pneumonia and 2 more. Started Nov 2008; status: completed.
02
Drugs
23-valent pneumococcal polysaccharide vaccine
03
Conditions
Pneumococcal pneumonia (PP)pneumonia
Beyond the preview
Go deeper on jRCT1090220024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1090220024.